Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RDEA594 vs placebo in hyperuricemia in patients with gout
2009-013055-30Phase 2Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gout and hyperuricemia comparing RDEA594 with Placebo (2 arms). Primary endpoint: Proportion of subjects with serum urate < 6.0 mg/dL at Day 28. Started Jun 2009; status: completed.
02
Drugs
lesinurad
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on 2009-013055-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013055-30.